Skip to main content
Top
Published in: CardioVascular and Interventional Radiology 8/2020

Open Access 01-08-2020 | Angiography | Clinical Investigation

Influence of Interventionists’ Experience on Radiation Exposure of Patients Who Underwent Prostate Artery Embolization: 4-Year Results from a Retrospective, Single-Center Study

Authors: Bernadette Maria Theresia Kriechenbauer, Tobias Franiel, Florian Bürckenmeyer, René Aschenbach, Ioannis Diamantis, Amer Malouhi, Beatrice Steiniger, Ulf Teichgräber

Published in: CardioVascular and Interventional Radiology | Issue 8/2020

Login to get access

Abstract

Purpose

To assess radiation exposure in men undergoing prostate artery embolization (PAE) for the treatment for symptomatic, benign prostatic hyperplasia depending on growing experience of interventional radiologists over a 4-year period.

Methods

A total of 250 consecutive patients underwent PAE at a single center. Data on radiation exposure [dose area product (DAP), effective dose (ED), entrance skin dose (ESD), and fluoroscopy time (FT)] were retrospectively evaluated. Primary outcomes of interest were patient radiation exposure in five consecutive groups of 50 patients each and Pearson correlation with the number of patients treated.

Results

Median DAP, ED, and ESD during prostate artery embolization were significantly higher in the first compared to the second 50 patients (56 298 µGym2 vs. 24 709 µGym2, p < 0.001, 146.4 mSv vs. 64.2 mSv, p < 0.001, and 5.1 Gy vs. 2.4 Gy, p < 0.001, respectively). The following consecutive groups did not differ significantly from the respective preceding group in terms of DAP, ED, and ESD. Number of digital subtraction angiography series, FT, and procedure time decreased with increasing operator experience (Pearson’s r = − 0.240, p < 0.001, r = − 0.269, p < 0.001, and r = − 0.504, p < 0.001, respectively). Bilateral prostate artery embolization was associated with less ESD and shorter FT than unilateral embolization (median 2.5 vs. 3.5 Gy, p = 0.02, and 26 min vs. 42 min, p < 0.001, respectively).

Conclusion

Exposure to radiation in men who underwent PAE decreased with growing operator experience and decreasing complexity of procedures.
Literature
1.
go back to reference Robert G, De La Taille A, Descazeaud A. Epidemiology of benign prostatic hyperplasia. Prog Urol. 2018;28(15):803–12.CrossRef Robert G, De La Taille A, Descazeaud A. Epidemiology of benign prostatic hyperplasia. Prog Urol. 2018;28(15):803–12.CrossRef
2.
go back to reference Christidis D, McGrath S, Perera M, Manning T, Bolton D, Lawrentschuk N. Minimally invasive surgical therapies for benign prostatic hypertrophy: the rise in minimally invasive surgical therapies. Prostate Int. 2017;5(2):41–6.CrossRef Christidis D, McGrath S, Perera M, Manning T, Bolton D, Lawrentschuk N. Minimally invasive surgical therapies for benign prostatic hypertrophy: the rise in minimally invasive surgical therapies. Prostate Int. 2017;5(2):41–6.CrossRef
3.
go back to reference Pisco JM, Rio Tinto H, Campos Pinheiro L, et al. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up. Eur Radiol. 2013;23(9):2561–72.CrossRef Pisco JM, Rio Tinto H, Campos Pinheiro L, et al. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up. Eur Radiol. 2013;23(9):2561–72.CrossRef
4.
go back to reference Malling B, Roder MA, Brasso K, Forman J, Taudorf M, Lonn L. Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Radiol. 2019;29(1):287–98.CrossRef Malling B, Roder MA, Brasso K, Forman J, Taudorf M, Lonn L. Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Radiol. 2019;29(1):287–98.CrossRef
5.
go back to reference Teoh JY, Chiu PK, Yee CH, et al. Prostatic artery embolization in treating benign prostatic hyperplasia: a systematic review. Int Urol Nephrol. 2017;49(2):197–203.CrossRef Teoh JY, Chiu PK, Yee CH, et al. Prostatic artery embolization in treating benign prostatic hyperplasia: a systematic review. Int Urol Nephrol. 2017;49(2):197–203.CrossRef
6.
go back to reference McClure TD, Ricke J. What Is new in prostate artery embolization for lower urinary tract symptoms? Eur Urol Focus. 2018;4(1):46–8.CrossRef McClure TD, Ricke J. What Is new in prostate artery embolization for lower urinary tract symptoms? Eur Urol Focus. 2018;4(1):46–8.CrossRef
7.
go back to reference Wang MQ, Duan F, Yuan K, Zhang GD, Yan J, Wang Y. Benign prostatic hyperplasia: cone-beam CT in conjunction with DSA for identifying prostatic arterial anatomy. Radiology. 2017;282(1):271–80.CrossRef Wang MQ, Duan F, Yuan K, Zhang GD, Yan J, Wang Y. Benign prostatic hyperplasia: cone-beam CT in conjunction with DSA for identifying prostatic arterial anatomy. Radiology. 2017;282(1):271–80.CrossRef
8.
go back to reference Teichgräber U, Aschenbach R, Diamantis I, von Rundstedt FC, Grimm MO, Franiel T. Prostate artery embolization: Indication, technique and clinical results. Rofo. 2018;190:847–55.CrossRef Teichgräber U, Aschenbach R, Diamantis I, von Rundstedt FC, Grimm MO, Franiel T. Prostate artery embolization: Indication, technique and clinical results. Rofo. 2018;190:847–55.CrossRef
9.
go back to reference Bagla S, Sterling KM. Pitfalls of cone beam computed tomography in prostate artery embolization. Cardiovasc Intervent Radiol. 2014;37(6):1430–5.CrossRef Bagla S, Sterling KM. Pitfalls of cone beam computed tomography in prostate artery embolization. Cardiovasc Intervent Radiol. 2014;37(6):1430–5.CrossRef
10.
go back to reference Hacking N, Vigneswaran G, Maclean D, et al. Technical and Imaging Outcomes from the UK Registry of Prostate Artery Embolization (UK-ROPE) Study: Focusing on Predictors of Clinical Success. Cardiovasc Intervent Radiol. 2019;42:666–76.CrossRef Hacking N, Vigneswaran G, Maclean D, et al. Technical and Imaging Outcomes from the UK Registry of Prostate Artery Embolization (UK-ROPE) Study: Focusing on Predictors of Clinical Success. Cardiovasc Intervent Radiol. 2019;42:666–76.CrossRef
11.
go back to reference United Nations Scientific Committee on Effects of Atomic Radiation. Unscear’s global survey of radiation exposure. 2017. survey.unscear.org. Accessed Feb 2020. United Nations Scientific Committee on Effects of Atomic Radiation. Unscear’s global survey of radiation exposure. 2017. survey.unscear.org. Accessed Feb 2020.
12.
go back to reference The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP. 2007;37(2–4):1–332. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP. 2007;37(2–4):1–332.
13.
go back to reference Miller DL, Balter S, Noonan PT, Georgia JD. Minimizing radiation-induced skin injury in interventional radiology procedures. Radiology. 2002;225(2):329–36.CrossRef Miller DL, Balter S, Noonan PT, Georgia JD. Minimizing radiation-induced skin injury in interventional radiology procedures. Radiology. 2002;225(2):329–36.CrossRef
14.
go back to reference Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126(5):1763–8.CrossRef Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126(5):1763–8.CrossRef
15.
go back to reference Schott P, Katoh M, Fischer N, Freyhardt P. Radiation dose in prostatic artery embolization using cone-beam CT and 3D roadmap software. J Vasc Interv Radiol. 2019;30(9):1452–8.CrossRef Schott P, Katoh M, Fischer N, Freyhardt P. Radiation dose in prostatic artery embolization using cone-beam CT and 3D roadmap software. J Vasc Interv Radiol. 2019;30(9):1452–8.CrossRef
16.
go back to reference Andrade G, Khoury HJ, Garzon WJ, et al. Radiation exposure of patients and interventional radiologists during prostatic artery embolization: a prospective single-operator study. J Vasc Interv Radiol. 2017;28(4):517–21.CrossRef Andrade G, Khoury HJ, Garzon WJ, et al. Radiation exposure of patients and interventional radiologists during prostatic artery embolization: a prospective single-operator study. J Vasc Interv Radiol. 2017;28(4):517–21.CrossRef
17.
go back to reference Alaei P, Spezi E. Imaging dose from cone beam computed tomography in radiation therapy. Phys Med. 2015;31(7):647–58.CrossRef Alaei P, Spezi E. Imaging dose from cone beam computed tomography in radiation therapy. Phys Med. 2015;31(7):647–58.CrossRef
18.
go back to reference Fisher DR, Fahey FH. Appropriate use of effective dose in radiation protection and risk assessment. Health Phys. 2017;113(2):102–9.CrossRef Fisher DR, Fahey FH. Appropriate use of effective dose in radiation protection and risk assessment. Health Phys. 2017;113(2):102–9.CrossRef
19.
go back to reference Hall EJ. Radiation biology for pediatric radiologists. Pediatr Radiol. 2009;39(Suppl 1):S57–64.CrossRef Hall EJ. Radiation biology for pediatric radiologists. Pediatr Radiol. 2009;39(Suppl 1):S57–64.CrossRef
20.
go back to reference Desai H, Yu H, Ohana E, Gunnell ET, Kim J, Isaacson A. Comparative analysis of cone-beam CT angiogram and conventional CT angiogram for prostatic artery identification prior to embolization. J Vasc Interv Radiol. 2018;29(2):229–32.CrossRef Desai H, Yu H, Ohana E, Gunnell ET, Kim J, Isaacson A. Comparative analysis of cone-beam CT angiogram and conventional CT angiogram for prostatic artery identification prior to embolization. J Vasc Interv Radiol. 2018;29(2):229–32.CrossRef
21.
go back to reference Garzon WJ, Andrade G, Dubourcq F, et al. Prostatic artery embolization: radiation exposure to patients and staff. J Radiol Prot. 2016;36(2):246–54.CrossRef Garzon WJ, Andrade G, Dubourcq F, et al. Prostatic artery embolization: radiation exposure to patients and staff. J Radiol Prot. 2016;36(2):246–54.CrossRef
22.
go back to reference Balter S, Miller DL. Patient skin reactions from interventional fluoroscopy procedures. AJR Am J Roentgenol. 2014;202(4):W335–W34242.CrossRef Balter S, Miller DL. Patient skin reactions from interventional fluoroscopy procedures. AJR Am J Roentgenol. 2014;202(4):W335–W34242.CrossRef
23.
go back to reference Miller DL, Balter S, Schueler BA, Wagner LK, Strauss KJ, Vano E. Clinical radiation management for fluoroscopically guided interventional procedures. Radiology. 2010;257(2):321–32.CrossRef Miller DL, Balter S, Schueler BA, Wagner LK, Strauss KJ, Vano E. Clinical radiation management for fluoroscopically guided interventional procedures. Radiology. 2010;257(2):321–32.CrossRef
24.
go back to reference du Pisanie J, Abumoussa A, Donovan K, Stewart J, Bagla S, Isaacson A. Predictors of prostatic artery embolization technical outcomes: patient and procedural factors. J Vasc Interv Radiol. 2019;30(2):233–40.CrossRef du Pisanie J, Abumoussa A, Donovan K, Stewart J, Bagla S, Isaacson A. Predictors of prostatic artery embolization technical outcomes: patient and procedural factors. J Vasc Interv Radiol. 2019;30(2):233–40.CrossRef
Metadata
Title
Influence of Interventionists’ Experience on Radiation Exposure of Patients Who Underwent Prostate Artery Embolization: 4-Year Results from a Retrospective, Single-Center Study
Authors
Bernadette Maria Theresia Kriechenbauer
Tobias Franiel
Florian Bürckenmeyer
René Aschenbach
Ioannis Diamantis
Amer Malouhi
Beatrice Steiniger
Ulf Teichgräber
Publication date
01-08-2020
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology / Issue 8/2020
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-020-02461-1

Other articles of this Issue 8/2020

CardioVascular and Interventional Radiology 8/2020 Go to the issue